» Articles » PMID: 34753768

Interventions to Improve Early Cancer Diagnosis of Symptomatic Individuals: a Scoping Review

Overview
Journal BMJ Open
Specialty General Medicine
Date 2021 Nov 10
PMID 34753768
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To summarise the current evidence regarding interventions for accurate and timely cancer diagnosis among symptomatic individuals.

Design: A scoping review following the Joanna Briggs Institute's methodological framework for the conduct of scoping reviews and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist.

Data Sources: MEDLINE (Ovid), CINAHL (EBSCOhost) and PsycINFO (Ovid) bibliographic databases, and websites of relevant organisations. Published and unpublished literature (grey literature) of any study type in the English language were searched for from January 2017 to January 2021.

Eligibility And Criteria: Study participants were individuals of any age presenting at clinics with symptoms indicative of cancer. Interventions included practice guidelines, care pathways or other initiatives focused on achieving predefined benchmarks or targets for wait times, streamlined or rapid cancer diagnostic services, multidisciplinary teams and patient navigation strategies. Outcomes included accuracy and timeliness of cancer diagnosis.

Data Extraction And Synthesis: We summarised findings graphically and descriptively.

Results: From 21 298 retrieved citations, 88 unique published articles and 16 unique unpublished documents (on 18 study reports), met the eligibility for inclusion. About half of the published literature and 83% of the unpublished literature were from the UK. Most of the studies were on interventions in patients with lung cancer. Rapid referral pathways and technology for supporting and streamlining the cancer diagnosis process were the most studied interventions. Interventions were mostly complex and organisation-specific. Common themes among the studies that concluded intervention was effective were multidisciplinary collaboration and the use of a nurse navigator.

Conclusions: Multidisciplinary cooperation and involvement of a nurse navigator may be unique features to consider when designing, delivering and evaluating interventions focused on improving accurate and timely cancer diagnosis among symptomatic individuals. Future research should examine the effectiveness of the interventions identified through this review.

Citing Articles

Developing a city-wide, community-engaged cancer disparities research agenda.

Leader A, Song Y, Gonzalez E, Fortune T, Graciani N, Zeigler-Johnson C Cancer Causes Control. 2024; 36(1):45-50.

PMID: 39340617 PMC: 11762217. DOI: 10.1007/s10552-024-01919-8.


Evaluation of online text-based information resources of gynaecological cancer symptoms.

DiSipio T, Scholte C, Diaz A Cancer Med. 2024; 13(9):e7167.

PMID: 38676385 PMC: 11053368. DOI: 10.1002/cam4.7167.


Cancer-Yesterday, Today, Tomorrow.

Grigorean V, Cristian D Medicina (Kaunas). 2023; 59(1).

PMID: 36676724 PMC: 9865199. DOI: 10.3390/medicina59010098.


Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation.

Iqbal M, Javed Z, Herrera-Bravo J, Sadia H, Anum F, Raza S Cancer Cell Int. 2022; 22(1):354.

PMID: 36376956 PMC: 9664821. DOI: 10.1186/s12935-022-02777-7.


Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature.

Dello Russo C, Navarra P Front Pharmacol. 2022; 13:858354.

PMID: 35652050 PMC: 9149259. DOI: 10.3389/fphar.2022.858354.

References
1.
Jacob L, Loosen S, Kalder M, Luedde T, Roderburg C, Kostev K . Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany. Cancers (Basel). 2021; 13(3). PMC: 7865307. DOI: 10.3390/cancers13030408. View

2.
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21(8):1023-1034. PMC: 7417808. DOI: 10.1016/S1470-2045(20)30388-0. View

3.
Nilbert M, Blackberg M, Ceberg J, Hagberg O, Stenhoff R, Liedberg F . Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria. Scand J Urol. 2018; 52(4):237-243. DOI: 10.1080/21681805.2018.1498124. View

4.
Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

5.
Brian T, Adams B, Jameson M . Cutaneous melanoma: an audit of management timeliness against New Zealand guidelines. N Z Med J. 2017; 130(1462):54-61. View